BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 12123608)

  • 21. Sema4A induces cell morphological changes through B-type plexin-mediated signaling.
    Yukawa K; Tanaka T; Yoshida K; Takeuchi N; Ito T; Takamatsu H; Kikutani H; Kumanogoh A
    Int J Mol Med; 2010 Feb; 25(2):225-30. PubMed ID: 20043131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FARP2 triggers signals for Sema3A-mediated axonal repulsion.
    Toyofuku T; Yoshida J; Sugimoto T; Zhang H; Kumanogoh A; Hori M; Kikutani H
    Nat Neurosci; 2005 Dec; 8(12):1712-9. PubMed ID: 16286926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grb2 mediates semaphorin-4D-dependent RhoA inactivation.
    Sun T; Krishnan R; Swiercz JM
    J Cell Sci; 2012 Aug; 125(Pt 15):3557-67. PubMed ID: 22505611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The semaphorin receptor plexin-B1 specifically interacts with active Rac in a ligand-dependent manner.
    Vikis HG; Li W; He Z; Guan KL
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12457-62. PubMed ID: 11035813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential.
    Chikumi H; Barac A; Behbahani B; Gao Y; Teramoto H; Zheng Y; Gutkind JS
    Oncogene; 2004 Jan; 23(1):233-40. PubMed ID: 14712228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular basis of RhoA specificity in the guanine nucleotide exchange factor PDZ-RhoGEF.
    Oleksy A; Opaliński Ł; Derewenda U; Derewenda ZS; Otlewski J
    J Biol Chem; 2006 Oct; 281(43):32891-7. PubMed ID: 16954208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4.
    Zhou H; Yang YH; Basile JR
    Angiogenesis; 2014 Jan; 17(1):261-74. PubMed ID: 24114199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG).
    Jaiswal M; Gremer L; Dvorsky R; Haeusler LC; Cirstea IC; Uhlenbrock K; Ahmadian MR
    J Biol Chem; 2011 May; 286(20):18202-12. PubMed ID: 21454492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation.
    Okuhira K; Fitzgerald ML; Tamehiro N; Ohoka N; Suzuki K; Sawada J; Naito M; Nishimaki-Mogami T
    J Biol Chem; 2010 May; 285(21):16369-77. PubMed ID: 20348106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary PDZ domain-binding site on class B plexins enhances the affinity for PDZ-RhoGEF.
    Pascoe HG; Gutowski S; Chen H; Brautigam CA; Chen Z; Sternweis PC; Zhang X
    Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14852-7. PubMed ID: 26627240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility.
    Basile JR; Gavard J; Gutkind JS
    J Biol Chem; 2007 Nov; 282(48):34888-95. PubMed ID: 17855350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct cytoplasmic domains in Plexin-A4 mediate diverse responses to semaphorin 3A in developing mammalian neurons.
    Mlechkovich G; Peng SS; Shacham V; Martinez E; Gokhman I; Minis A; Tran TS; Yaron A
    Sci Signal; 2014 Mar; 7(316):ra24. PubMed ID: 24619647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semaphorin-4D (Sema-4D), the Plexin-B1 ligand, is involved in mouse ovary follicular development.
    Regev A; Goldman S; Shalev E
    Reprod Biol Endocrinol; 2007 Mar; 5():12. PubMed ID: 17376242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The plexin-B1/Rac interaction inhibits PAK activation and enhances Sema4D ligand binding.
    Vikis HG; Li W; Guan KL
    Genes Dev; 2002 Apr; 16(7):836-45. PubMed ID: 11937491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modular architecture and novel protein-protein interactions regulating the RGS-containing Rho guanine nucleotide exchange factors.
    Vázquez-Prado J; Basile J; Gutkind JS
    Methods Enzymol; 2004; 390():259-85. PubMed ID: 15488183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.
    Bourguignon LY; Gilad E; Brightman A; Diedrich F; Singleton P
    J Biol Chem; 2006 May; 281(20):14026-40. PubMed ID: 16565089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation.
    Medlin MD; Staus DP; Dubash AD; Taylor JM; Mack CP
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1779-86. PubMed ID: 20702813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A conserved hydrophobic surface of the LARG pleckstrin homology domain is critical for RhoA activation in cells.
    Aittaleb M; Gao G; Evelyn CR; Neubig RR; Tesmer JJ
    Cell Signal; 2009 Nov; 21(11):1569-78. PubMed ID: 19560536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plexin-B semaphorin receptors interact directly with active Rac and regulate the actin cytoskeleton by activating Rho.
    Driessens MH; Hu H; Nobes CD; Self A; Jordens I; Goodman CS; Hall A
    Curr Biol; 2001 Mar; 11(5):339-44. PubMed ID: 11267870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A functional role for semaphorin 4D/plexin B1 interactions in epithelial branching morphogenesis during organogenesis.
    Korostylev A; Worzfeld T; Deng S; Friedel RH; Swiercz JM; Vodrazka P; Maier V; Hirschberg A; Ohoka Y; Inagaki S; Offermanns S; Kuner R
    Development; 2008 Oct; 135(20):3333-43. PubMed ID: 18799546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.